These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 5060262)
21. [On the therapy of cerebral and peripheral circulatory disorders in general practice]. Risse S Med Welt; 1967 Jul; 28():1659-62. PubMed ID: 5612140 [No Abstract] [Full Text] [Related]
22. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)]. Lehrach F; Müller R Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012 [No Abstract] [Full Text] [Related]
23. [Gerontologic problems in circulatory disorders of the lower extremities]. Sprung O Phlebologie; 1968; 21(2):143-6. PubMed ID: 5679609 [No Abstract] [Full Text] [Related]
24. [Effect of a new vascular drug, 4216 S, on circulatory flow in patients with chronic angiopathy of the lower extremities: determination of an index of vascularization of the lower extremities by serum albumin tagged with iodine 131]. Dugois P; Bignicourt B Lyon Med; 1969 Jul; 222(27):43-7. PubMed ID: 5398723 [No Abstract] [Full Text] [Related]
25. [Study of the effects of intravenous administration of a synthetic adrenaline derivative of 1-(4-oxy-phenyl)-1-oxy-2-N-butylamino-ethane sulphate in central and peripheral vascular diseases]. Grosso F; Riva F Minerva Cardioangiol; 1973 May; 21(5):375-80. PubMed ID: 4145542 [No Abstract] [Full Text] [Related]
26. [Defluine (an association of raubasine and ergot derivatives) in the treatment of senile cerebral vascular diseases of a sclerotic nature]. Turri C Minerva Med; 1970 Aug; 61(65):3466-76. PubMed ID: 5451093 [No Abstract] [Full Text] [Related]
27. [Electrotherapy in circulatory disorders of the legs]. Guillemin R; Commandre F; Bonelli AJ Electrodiagn Ther; 1977; 14(1):5-8. PubMed ID: 301466 [No Abstract] [Full Text] [Related]
29. [Various types of circulatory disorders of the extremities, especially of the upper extremities, and an evaluation of therapeutic indications]. Tajima T; Kobayashi S Seikei Geka; 1965 Apr; 16(5):397-409. PubMed ID: 5894346 [No Abstract] [Full Text] [Related]
30. [Effect of anginin administration in chronic obstructive arterial diseases of the lower extremity, with special reference to the determination of therapeutic effect using the dye index curve]. Kaneko Y; Fukuzumi H; Uemichi A; Harada S; Uehara N Geka Chiryo; 1970 Apr; 22(4):465-8. PubMed ID: 4915897 [No Abstract] [Full Text] [Related]
31. Remission in progressive multifocal leukoencephalopathy. Thompson RA; Jones M Neurology; 1968 Mar; 18(3):308. PubMed ID: 5690420 [No Abstract] [Full Text] [Related]
32. [Diagnosis of the arterial circulatory disorders]. Schoop W Landarzt; 1966 Feb; 42(5):193-200. PubMed ID: 5982105 [No Abstract] [Full Text] [Related]
33. [A new method of treating arteriopathy of the extremities with a pharmacologically original substance]. Royer R; Debry G; Duc M Therapeutique; 1969 Mar; 45(3):308-12. PubMed ID: 5386064 [No Abstract] [Full Text] [Related]
34. [On the therapy of peripheral circulatory disorders with the new angioactivator Tebonin of plant origin]. Krammer F Med Welt; 1966 Jul; 28():1524-8. PubMed ID: 5984513 [No Abstract] [Full Text] [Related]
35. [Experiences with bencyclane in the therapy of peripheral blood circulation disorders]. von Thümen WD Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1428+. PubMed ID: 5536662 [No Abstract] [Full Text] [Related]
36. [Relationship between blood flow values of the upper and the lower extremities and effects of a vasoactive agent in persons with normal circulation and patients with vascular diseases]. Caesar K Med Welt; 1971 Apr; 14():559-62. PubMed ID: 5551942 [No Abstract] [Full Text] [Related]
37. [Experiences with the new venous therapeutic agent, opino-gel]. Harrichhausen KH Ther Ggw; 1968 Apr; 107(4):549-52. PubMed ID: 5672327 [No Abstract] [Full Text] [Related]
38. [Tebonin in chronic cerebral ischemia]. Birkmayer W; Danielczyk W Med Klin; 1967 Mar; 62(11):421-4. PubMed ID: 5586146 [No Abstract] [Full Text] [Related]